Aug 1, 2024 7:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 11, 2024 7:30 am EDT Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
Jun 3, 2024 7:30 am EDT Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2024 7:30 am EDT Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
May 15, 2024 7:30 am EDT Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
May 7, 2024 7:30 am EDT Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 3, 2024 7:30 am EDT Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Apr 1, 2024 8:30 am EDT Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
